Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cibus, Inc.
Report date March 01, 2023 · Filed June 02, 2023
Section 16 reporting ended · disclosed 2023-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,506 |
Reported balance
After 2023-05-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-31 · Grant · Acquired 6,333 · Balance 19,506 F1: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.55 · Expires 2030-08-04 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-01 · Disposition to issuer · Disposed 110,000 · Balance 0 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.55 · Expires 2030-08-04 | Direct | 110,000 |
Reported balance
After 2023-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-01 · Grant · Acquired 110,000 · Balance 110,000 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.05 · Expires 2031-03-12 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-03-01 · Disposition to issuer · Disposed 26,000 · Balance 0 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.05 · Expires 2031-03-12 | Direct | 26,000 |
Reported balance
After 2023-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-01 · Grant · Acquired 26,000 · Balance 26,000 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.27 · Expires 2032-03-24 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-03-01 · Disposition to issuer · Disposed 250,000 · Balance 0 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.27 · Expires 2032-03-24 | Direct | 250,000 |
Reported balance
After 2023-03-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-03-01 · Grant · Acquired 250,000 · Balance 250,000 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023.
F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2023 Filed Jun 2, 2023 20:35 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 6,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,506 F1 · shares: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. F1 · balance_after: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. Read SEC document |
| March 30, 2023 Filed Mar 31, 2023 16:43 UTC | Cibus, Inc. CLXT · Entity 6658 | OtherCommon Stock | 10,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000025 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 658,645 F1 · kind: Shares were transferred to reporting person's ex-spouse pursuant to a divorce decree. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 16:17 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 11,967 | $0.34 | $4,068.78 |
DisclosureSEC source: 0001615594-23-000024 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 669,590 F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3363 to $0.355, inclusive. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 16:40 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 2,483 | $0.31 | $769.73 |
DisclosureSEC source: 0001615594-23-000018 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,557 F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3045 to $0.33, inclusive. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 16:08 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 11,967 | $0.43 | $5,147.01 |
DisclosureSEC source: 0001615594-23-000013 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,040 F1 · shares: Shares were sold to cover tax withholding obligations of reporting person in connection with the vesting of Performance Stock Units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:36 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000011 · primary_doc.xml · nonDerivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 696,007 F2 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:36 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 473,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000011 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,674 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 7 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 6 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 26,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 5 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 26,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 4 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 110,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 3 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 110,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 110,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| February 07, 2023 Filed Feb 8, 2023 16:59 UTC | Cibus, Inc. CLXT · Entity 6658 | OtherCommon Stock | 23,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000007 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,774 F1 · kind: Shares transferred to reporting person's ex-spouse pursuant to a divorce decree. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 16:35 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 42,570 | $0.15 | $6,279.08 |
DisclosureSEC source: 0001615594-23-000002 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,525 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 19:02 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 250,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001615594-22-000021 · primary_doc.xml · derivative · entry 3 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F3 · derivative.exercise_date: Option vests as to 25% on each of the first four anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 19:02 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 119,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000021 · primary_doc.xml · nonDerivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,095 F2 · shares: The Restricted Stock Units reported on this Form 4 vest in full on January 1, 2023. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 19:02 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000021 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,395 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 18:19 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 2,605 | $1.05 | $2,739.94 |
DisclosureSEC source: 0001615594-22-000013 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,395 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 22, 2021. F2 · price: The price reported in Column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.05 to $1.06, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 16:31 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 20,000 | $3.21 | $64,112.00 |
DisclosureSEC source: 0001615594-21-000095 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 F1 · price: The price reported in Column 4 is a weighted average. The shares were purchased in multiple transactions at prices ranging from $3.18 to $4.1799, inclusive. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 16:49 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantRestricted Stock Units · Derivative | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000031 · primary_doc.xml · derivative · entry 3 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Calyxt, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 12, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 12, 2022. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 16:49 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 26,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000031 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2031-03-12 F1 · derivative.exercise_date: Options vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 16:52 UTC Amendment | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 26,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000044 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2031-03-12 F2 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 16:52 UTC Amendment | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000044 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 18:39 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 110,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000054 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 12:45 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantPerformance Stock Units · Derivative | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-19-000025 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2022-06-28 F1 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one share of Calyxt common stock. The PSU will vest as to 50%, 100% or 120% of the shares at the end of a three year performance period based upon increases in Calyxt common stock from the starting price of $12.48 (and on a linear basis between vesting percentages) and if vested, will be issued as restricted stock with restrictions lapsing on the two year anniversary of the date of issuance. F1 · derivative.exercise_date: Each performance stock unit (PSU) represents a contingent right to receive one share of Calyxt common stock. The PSU will vest as to 50%, 100% or 120% of the shares at the end of a three year performance period based upon increases in Calyxt common stock from the starting price of $12.48 (and on a linear basis between vesting percentages) and if vested, will be issued as restricted stock with restrictions lapsing on the two year anniversary of the date of issuance. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 08:18 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $13.01 | $0.00 |
DisclosureSEC source: 0001127602-19-005213 · form4.xml · derivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2029-02-08 F1 · derivative.exercise_date: The stock option to purchase shares of Calyxt, Inc. common stock was granted on February 8, 2019 and vests 15% on the first anniversary of the date of grant and 10% on the second anniversary of the date of grant, with the remainder vesting quarterly in equal installments over the following 45 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.